// // //
Type 2 diabetes mellitus (T2DM) is increasingly prevalent in the United States, and cardiovascular disease (CVD) is the leading cause of mortality associated with this chronic disease. Many different healthcare providers (HCPs; eg, cardiologists, endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, diabetes educators) play important roles in the management of patients throughout the course of T2DM. Therefore, all these HCPs should be knowledgeable about the interrelated risks of diabetes, glycemic control, and CVD. In particular, HCPs managing patients with T2DM need to be aware of the benefits and limitations of intensive glycemic control, especially those that affect CV health. HCPs should also be aware of the clinically important differences in CV outcomes with the major classes of agents used to treat T2DM.
The written content for this activity is enhanced with audio commentary in which the authors discuss 2 T2DM patient cases and how to identify the most suitable treatment options for these patients.